QuickLinks
 -- Click here to rapidly navigate through this document





































 



 
 

  Exhibit 10.9    
    


 
    SUMMARY OF COMPENSATION ARRANGEMENTS
  WITH NON-EMPLOYEE DIRECTORS    
    


        The following description of the compensation arrangements between Allos Therapeutics, Inc. (the
"Company") and each of its non-employee directors is provided pursuant to Item 601(b)(10)(iii) of Regulation S-K,
which requires a written description of any compensatory plan or arrangement between a registrant and any of its directors when the compensation information is not set forth in any formal document. 


        The
type and amount of compensation paid or awarded to the Company's non-employee directors is reviewed from time to time by the Compensation Committee (the
"Compensation Committee") of the Company's Board of Directors (the "Board"). In order to retain the
services of the Company's current non-employee directors, to secure and retain the services of new non-employee directors, and to provide competitive compensation for such
persons' services as directors of the Company, the Compensation Committee recommended and the Board approved the following compensation arrangements for the Company's non-employee
directors effective February 16, 2012:



	•
	The Company will pay the Chairman of the Board an annual retainer of $60,000, and will pay each other director an annual
retainer of $40,000, such retainers to be paid in four equal quarterly installments on the first day of each calendar quarter. 



	•
	The Company will pay (i) each director who serves as Chairman of the Audit Committee an annual retainer of $20,000,
(ii) each director who serves as Chairman of the Compensation Committee an annual retainer of $12,500, and (iii) each director who serves as Chairman of any other committee of the Board
an annual retainer of $7,500, such retainers to be paid in four equal quarterly installments on the first day of each calendar quarter. 



	•
	The Company will pay (i) each director who serves as a member of the Audit Committee (other than the Chairman) an
annual retainer of $10,000, and (ii) each director who serves as a member of any other committee of the Board (other than the Chairman) an annual retainer of $5,000, such retainers to be paid
in four equal quarterly installments on the first day of each calendar quarter. 



	•
	In addition to the annual retainers set forth above, the Company will pay each director who serves as a member of the
Transaction Committee of the Board (as in effect from time to time) a fee of $1,000 for each meeting of the Transaction Committee that such director attends in person or by conference telephone, such
fees to apply retroactively to all meetings of the Transaction Committee occurring on or after December 28, 2011. 



	•
	The Company will reimburse each director all reasonable out-of-pocket expenses incurred by such
director in connection with attending any regular or special meeting of the Board or any regular or special meeting of any committee of the Board. 



	•
	The Company will grant each person who becomes Chairman of the Board of Directors after the date hereof 90,000 restricted
stock units of the Company ("RSUs") under the Company's 2008 Equity Incentive Plan, as amended (the
"Plan"), on the date of his or her initial election, and will grant each other person who becomes a director of the Company after the date hereof 55,000
RSUs under the Plan on the date of his or her initial election (each, an "Initial Grant"). Each Initial Grant shall (i) be subject to the terms
and conditions of the Plan and (ii) vest in equal installments on each of the first and second anniversaries of the date of grant, assuming continued service on the Board for such periods.  



	•
	The Company will grant the Chairman of the Board of Directors a nonqualified stock option under the Plan to purchase
30,000 shares of the Company's common stock immediately following each year's annual meeting of stockholders, and shall grant each other director a nonqualified stock option under the Plan to purchase
20,000 shares of the Company's common stock immediately following each year's annual meeting of stockholders (each, an "Annual  








 


 Grant"); provided that any director who received an Initial Grant within three months prior to an annual meeting of stockholders shall not receive an Annual Grant until
immediately following the second annual meeting of stockholders after the date of his or her Initial Grant. Each Annual Grant shall (i) be subject to the terms and conditions of the Plan,
(ii) be exercisable for a term of ten (10) years measured from the date of grant at a price per share equal to the closing price of the Company's common stock as quoted on the Nasdaq
National Market on the date of grant, and (iii) vest in full on the date of the next succeeding annual meeting of stockholders, assuming continued service on the Board for such period. 




2















QuickLinks



Exhibit 10.9


SUMMARY OF COMPENSATION ARRANGEMENTS WITH NON-EMPLOYEE DIRECTORS